NMDA receptors and metaplasticity: Mechanisms and possible roles in neuropsychiatric disorders

Neuroscience and Biobehavioral Reviews

Volumn 36, Issue 3, 2012, Pages 989-1000

  Zorumski, Charles F ^a   Izumi, Yukitoshi ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delirium; Dementia; Hippocampus; Ketamine; Metaplasticity; Neurosteroids; Synaptic plasticity

Indexed keywords

ALCOHOL; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EXCITOTOXIN; GLYCOGEN SYNTHASE KINASE 3; KETAMINE; MAMMALIAN TARGET OF RAPAMYCIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; PHENCYCLIDINE; STRESS ACTIVATED PROTEIN KINASE;

AMINO TERMINAL SEQUENCE; AUTISM; BRAIN FUNCTION; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; COGNITIVE DEFECT; DOWN REGULATION; DRUG EXPOSURE; ENZYME ACTIVATION; EPILEPSY; GENE MUTATION; GENETIC POLYMORPHISM; GLYCOLYSIS; HIPPOCAMPUS; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MENTAL DEFICIENCY; MENTAL DISEASE; METAPLASTICITY; MOOD DISORDER; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; POSTERIOR CINGULATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS;

HIPPOCAMPUS; HUMANS; LEARNING; LEARNING DISORDERS; LONG-TERM POTENTIATION; MEMORY; MEMORY DISORDERS; NEURONAL PLASTICITY; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84856180208     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.12.011     Document Type: Review

References (168)

1. Aarts M.M., Tymianski M. Molecular mechanisms underlying specificity of excitotoxic signaling in neurons. Curr. Mol. Med. 2004, 4:137-147.
2. Abraham W.C. Metaplasticity: tuning synapses and networks for plasticity. Nat. Rev. Neurosci. 2008, 9:387-399.
3. Abraham W.C., Bear M.F. Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci. 1996, 19:126-130.
4. Abraham W.C., Tate W.P. Metaplasticity: a new vista across the field of synaptic plasticity. Prog. Neurobiol. 1997, 52:303-323.
5. Abraham W.C., Mason-Parker S.E., Bear M.F., Webb S., Tate W.P. Heterosynaptic metaplasticity in the hippocampus in vivo: a BCM-like modifiable threshold for LTP. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10924-10929.
6. Agís-Balboa R.C., Pinna G., Zhubi A., Maloku E., Veldic M., Costa E., Guidotti A. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:14602-14607.
7. Airan R.D., Meltzer L.A., Roy M., Gong Y., Chen H., Deisseroth K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 2007, 317:819-823.
8. Anwyl R. Induction and expression mechanisms of postsynaptic NMDA receptor-independent homosynaptic long-term depression. Prog. Neurobiol. 2006, 78:17-37.
9. Artola A. Diabetes-, stress- and aging-related changes in synaptic plasticity in hippocampus and neocortex-the same metaplastic process?. Eur. J. Pharmacol. 2008, 585:153-162.
10. Autry A.E., Adachi M., Nosyreva E., Na E.S., Los M.F., Cheng P.-F., Kavalali E.T., Monteggia L.M. NMDA receptor blockade at rest triggers rapid behavioral antidepressant responses. Nature 2011, 475:91-95.
11. Barkus C., McHugh S.B., Sprengel R., Seeburg P.H., Rawlins J.N., Bannerman D.M. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur. J. Pharmacol. 2009, 626:49-56.
12. Bartlett T.E., Bannister N.J., Collett V.J., Dargan S.L., Massey P.V., Bortolotto Z.A., Fitzjohn S.M., Bashir Z.I., Collingridge G.L., Lodge D. Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology 2007, 52:60-70.
13. Bayes A., van de Lagemaat L.N., Collins M.O., Croning M.D., Whittle I.R., Choudhary J.S., Grant S.G. Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat. Neurosci. 2011, 14:19-21.
14. Beal M.F., Hyman B.T., Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?. Trends Neurosci. 1993, 16:125-131.
15. A receptor. Nat. Rev. Neurosci. 2005, 6:565-575.
16. Berberich S., Punnakkal P., Jensen M., Pawlak V., Seeburg P.H., Hvalby O., Kohr G. Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. J. Neurosci. 2005, 25:6907-6910.
17. Bettini E., Sava A., Griffante C., Carignani C., Buson A., Capelli A.M., Negri M., Andreetta F., Senar-Sancho S.A., Guiral L., Cardullo F. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. J. Pharmacol. Exp. Ther. 2010, 335:636-644.
18. Bienenstock E.L., Cooper L.N., Munro P.W. Theory for the development of neuron selectivity: orientation specificity and binocular interaction in visual cortex. J. Neurosci. 1982, 2:32-48.
19. Bittigau P., Sifringer M., Genz K., Reith K., Pospischil D., Govindarajalu S., Dzietko M., Pesditschek S., Mai I., Dikranian K., Olney J.W., Ikonomidou C. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15089-15094.
20. Bodhinathan K., Kumar A., Foster T.C. Redox sensitive calcium stores underlie enhanced after hyperpolarization of aged neurons: role for ryanodine receptor mediated calcium signaling. J. Neurophysiol. 2010, 104:2586-2593.
21. Bolshakov V.Y., Carboni L., Cobb M.H., Siegelbaum S.A., Belardetti F. Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses. Nat. Neurosci. 2000, 3:1107-1112.
22. Boultadakis A., Pitsikas N. Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat. Neuropsychopharmacology 2010, 35:2357-2366.
23. Burke S.N., Barnes C.A. Senescent synapses and hippocampal circuit dynamics. Trends Neurosci. 2010, 33:153-161.
24. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M.G. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8:766-775.
25. Chohan M.O., Iqbal K. From tau to toxicity: emerging roles of NMDA receptor in Alzheimer's disease. J. Alzheimers Dis. 2006, 10:81-87.
26. Coan E.J., Irving A.J., Collingridge G.L. Low frequency activation of the NMDA receptor system can prevent the induction of LTP. Neurosci. Lett. 1989, 105:205-210.
27. Coba M.P., Pocklington A.J., Collins M.O., Kopanitsa M.V., Uren R.T., Swamy S., Croning M.D.R., Choudhary J.S., Grant S.G.N. Neurotransmitters drive combinatorial multistate postsynaptic density networks. Sci. Signal. 2009, 2:ra19.
28. Cormier R.J., Greenwood A.C., Connor J.A. Bidirectional synaptic plasticity correlated with the magnitude of dendritic calcium transients above a threshold. J. Neurophysiol. 2001, 85:399-406.
29. A receptors. Brain Res. Rev. 2001, 37:91-97.
30. Creeley C., Wozniak D.F., Labruyere J., Taylor G.T., Olney J.W. Low doses of memantine disrupt memory in adult rats. J. Neurosci. 2006, 26:3923-3932.
31. Cull-Candy S.G., Leszkiewicz D.N. Role of distinct NMDA receptor subtypes at central synapses. Sci. STKE 2004, 255:re16.
32. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 2001, 11:327-335.
33. Cummings J.A., Nicola S.M., Malenka R.C. Induction in the rat hippocampus of long-term potentiation (LTP) and long-term depression (LTD) in the presence of a nitric oxide synthase inhibitor. Neurosci. Lett. 1994, 176:110-114.
34. Diamond D.M., Park C.R., Campbell A.M., Woodson J.C. Competitive interactions between endogenous LTD and LTP in the hippocampus underlie the storage of emotional memories and stress-induced amnesia. Hippocampus 2005, 15:1006-1025.
35. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 1999, 51:7-61.
36. Dong E., Matsumoto K., Uzunova V., Sugaya I., Takahata H., Nomura H., Watanabe H., Costa E., Guidotti A. Brain 5-alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:2849-2854.
37. Dudek S.M., Bear M.F. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-d-aspartate receptor blockade. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:4363-4367.
38. Espinosa F., Kavalali E.T. NMDA receptor activation by spontaneous glutamatergic neurotransmission. J. Neurophysiol. 2009, 101:2290-2296.
39. Foy M.R., Stanton M.E., Levine S., Thompson R.F. Behavioral stress impairs long-term potentiation in rodent hippocampus. Behav. Neural. Biol. 1987, 48:138-149.
40. Francis P.T. Altered glutamate neurotransmission and behavior in dementia: evidence from studies of memantine. Curr. Mol. Pharmacol. 2009, 2:77-82.
41. 2+ in hippocampal slices. Neuropharmacology 1999, 38:1253-1259.
42. Franks K.M., Sejnowski T.J. Complexity of calcium signaling in synaptic spines. Bioessays 2002, 24:1130-1144.
43. Fujii S., Saito K., Miyakawa H., Ito K., Kato H. Reversal of long-term potentiation (depotentiation) induced by tetanus stimulation of the input to CA1 neurons of guinea pig hippocampal slices. Brain Res. 1991, 555:112-122.
44. Fujii S., Kuroda Y., Ito K.-I., Yoshioka M., Kaneko K., Yamazaki Y., Sasaki H., Kato H. Endogenous adenosine regulates the effects of low-frequency stimulation on the induction of long-term potentiation in CA1 neurons of guinea pig hippocampal slices. Neurosci. Lett. 2000, 279:121-1224.
45. Girdler S.S., Klatzkin R. Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol. Therap. 2007, 116:125-139.
46. Gisabella B., Rowan M.J., Anwyl R. Mechanisms underlying the inhibition of long-term potentiation by preconditioning stimulation in the hippocampus in vitro. Neuroscience 2003, 121:297-305.
47. Gofton T.E. Delirium: a review. Can. J. Neurol. Sci. 2011, 38:673-680.
48. Gray J.A., Shi Y., Usui H., During M.J., Sakimura K., Nicoll R.A. Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron 2011, 71:1085-1101.
49. Guix F.X., Uribesalgo I., Coma M., Munoz F.J. The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol. 2005, 76:126-152.
50. Hardingham G.E., Bading H. The yin and yang of NMDA receptor signaling. Trends Neurosci. 2003, 26:81-89.
51. Hardingham G.E., Bading H. Synaptic versus extrasynaptic NMDA receptor signaling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 2010, 11:682-696.
52. Hrabetova S., Serrano P., Blace N., Tse H.W., Skifter D.A., Jane D.E., Monaghan D.T., Saktor T.C. Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction. J. Neurosci. 2000, 20:RC81.
53. Huang Y.-Y., Colino A., Selig D.K., Malenka R.C. The influence of prior synaptic activity on the induction of long-term potentiation. Science 1992, 255:730-733.
54. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999, 283:70-74.
55. Ikonomidou C., Bittigau P., Ishimaru M.J., Wozniakm D.F., Koch C., Genz K., Price M.T., Stefovska V., Horster F., Tenkova T., Dikranian K., Olney J.W. Ethanol-induced apoptotic neurodegeneration and the fetal alcohol syndrome. Science 2000, 287:1056-1060.
56. Izumi Y., Zorumski C.F. Nitric oxide and long-term synaptic depression in the rat hippocampus. NeuroReport 1993, 4:1131-1134.
57. Izumi Y., Zorumski C.F. Involvement of nitric oxide in low glucose-mediated inhibition of hippocampal long-term potentiation. Synapse 1997, 25:258-262.
58. Izumi Y., Zorumski C.F. Norepinephrine promotes long-term potentiation in the adult rat hippocampus in vitro. Synapse 1999, 31:196-202.
59. Izumi Y., Zorumski C.F. Direct cortical inputs erase long-term potentiation at Schaffer collateral synapses. J. Neurosci. 2008, 28:9557-9563.
60. Izumi Y., Zorumski C.F. Neuroprotective effects of pyruvate following NMDA-mediated excitotoxic insults in hippocampal slices. Neurosci. Lett. 2010, 478:131-135.
61. Izumi Y., Clifford D.B., Zorumski C.F. Low concentrations of N-methyl-d-aspartate inhibit the induction of long-term potentiation in rat hippocampal slices. Neurosci. Lett. 1992, 137:245-248.
62. Izumi Y., Clifford D.B., Zorumski C.F. Norepinephrine reverses N-methyl-d-aspartate-mediated inhibition of long-term potentiation in rat hippocampal slices. Neurosci. Lett. 1992, 142:163-166.
63. Izumi Y., Clifford D.B., Zorumski C.F. Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science 1992, 257:1273-1276.
64. Izumi Y., Katsuki H., Benz A.M., Zorumski C.F. Oxygen deprivation produces delayed inhibition of LTP by activation of NMDA receptors and nitric oxide synthase. J. Cerebral Bl. Fl. Metab. 1998, 18:97-108.
65. Izumi Y., Izumi M., Matsukawa M., Funatsu M., Zorumski C.F. Ammonia-mediated LTP inhibition: effects of NMDA receptor antagonists and l-carnitine. Neurobiol. Dis. 2005, 20:615-624.
66. Izumi Y., Kitabayashi R., Funatsu M., Izumi M., Yuede C., Hartman R.E., Wozniak D.F., Zorumski C.F. A single day of ethanol exposure during development has persistent effects on bi-directional plasticity, NMDA receptor function and ethanol sensitivity. Neuroscience 2005, 136:269-279.
67. Izumi Y., Nagashima K., Murayama K., Zorumski C.F. Acute effects of ethanol on hippocampal LTP and LTD are mediated by different mechanisms. Neuroscience 2005, 136:509-517.
68. Izumi Y., Murayama K., Tokuda K., Krishnan K., Covey D.F., Zorumski C.F. GABAergic neurosteroids mediate the effects of ethanol on long-term potentiation in rat hippocampal slices. Eur. J. Neurosci. 2007, 26:1881-1888.
69. Javitt D.C. Glutamate as a therapeutic target in psychiatric disorders. Mol. Psychiatry 2004, 9:984-997.
70. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., Benshoff N.D., Dikranian K., Zorumski C.F., Olney J.W., Wozniak D.F. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 2003, 23:876-882.
71. Jo J., Whitcomb D.J., Olsen K.M., Kerrigan T.L., Lo S.-C., Bru-Mercier G., Dickinson B., Scullion S., Sheng M., Collingridge G., Cho K. Aβ1-42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β. Nat. Neurosci. 2011, 14:545-547.
72. Joels M. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol. Sci. 2006, 27:244-250.
73. Joels M., Kruger H.J. LTP after stress: up or down?. Neural Plast. 2007, 93202.
74. Kato K., Zorumski C.F. Nitric oxide inhibitors facilitate the induction of hippocampal long-term potentiation by modulating NMDA responses. J. Neurophysiol. 1993, 70:1260-1263.
75. Kato K., Li S.-T., Zorumski C.F. Modulation of LTP induction in the hippocampus by NMDA-mediated presynaptic inhibition. Neuroscience 1999, 92:1261-1272.
76. Katsuki H., Izumi Y., Zorumski C.F. Noradrenergic regulation of synaptic plasticity in the hippocampal CA1 region. J. Neurophysiol. 1997, 77:3013-3020.
77. Kemp A., Manahan-Vaughan D. Hippocampal long-term depression: master or minion in declarative memory processes?. Trends Neurosci. 2007, 30:111-118.
78. Kim J.J., Diamond D.M. The stressed hippocampus, synaptic plasticity and lost memories. Nat. Rev. Neurosci. 2002, 3:453-462.
79. Kim J.J., Foy M.R., Thompson R.F. Behavioral stress modifies hippocampal plasticity through N-methyl-d-aspartate receptor activation. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:4750-4753.
80. Kim J.-I., Lee H.-R., Sim S., Baek J., Yu N.-K., Choi J.-H., Ko H.-G., Lee Y.-S., Park S.-W., Kwak C., Ahn S.-J., Choi S.Y., Kim H., Kim K.-H., Backx P.H., Bradley C.A., Kim E., Jang D.-J., Lee K., Kim S.J., Zhuo M., Collingridge G.L., Kaang B.-K. PI3Kγ is required for NMDA receptor-dependent long-term depression and behavioral flexibility. Nat. Neurosci. 2011, 14:1447-1454.
81. Kimoto T., Tsurugizwa T., Ohta Y., Makino J., Tamura H.-O., Hojo Y., Takata N., Kawato S. Neurosteroid synthesis by cytochrome p450-containing systems localized in rat brain hippocampal neurons: N-methyl-d-aspartate and calcium-dependent synthesis. Endocrinology 2001, 142:3578-3589.
82. Krugers H.J., Zhou M., Joels M., Kindt M. Regulation of excitatory synapses and fearful memories by stress hormones. Front. Behav. Neurosci. 2011, 5:1-11.
83. Lavaque E., Sierra A., Azcoitia I., Garcia-Segura L.M. Steroidogenic acute regulatory protein in the brain. Neuroscience 2006, 138:741-747.
84. Lee H.K., Kameyama K., Huganir R.L., Bear M.F. NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors I hippocampus. Neuron 1998, 21:1151-1162.
85. Lei S.Z., Pan Z.-H., Aggarwal S.K., Chen H-S.C., Hartman J., Sucher N.J., Lipton S.A. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 1992, 8:1087-1099.
86. Li N., Lee B., Liu R.-J., Banasr M., Dwyer J.M., Iwata M., Li X.-Y., Aghajanian G., Duman R.S. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
87. Li Z., Jo J., Jia J.M., Lo S.C., Whitcomb D.J., Jiao S., Cho K., Sheng M. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 2010, 141:859-871.
88. Li S., Jin M., Koeglsperger T., Shepardson N.E., Shankar G.M., Selkoe D.J. Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J. Neurosci. 2011, 31:6627-6638.
89. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999, 79:1431-1568.
90. 2+ levels affect plasticity differently: the LTP zone, the LTD zone and no man's land. J. Physiol. 2001, 532:1469-1473.
91. Loftis J.M., Janowsky A. The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation and clinical implications. Pharmacol. Therap. 2003, 97:55-85.
92. Luo J., Wang Y., Yasuda R.P., Dunah A.W., Wolfe B.B. The majority of N-methyl-d-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol. Pharmacol. 1997, 51:79-86.
93. Ma Y.Y., Cepeda C., Cui C.L. The role of striatal NMDA receptors in drug addiction. Int. Rev. Neurobiol. 2009, 89:131-146.
94. Machado-Vieira R., Salvadore G., Diazgranados N., Zarate C.A. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol. Ther. 2009, 123:143-150.
95. MacQueen G., Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?. Mol. Psychiatry 2011, 16:252-264.
96. Malenka R.C., Bear M.F. LTP and LTD: an embarassment of riches. Neuron 2004, 44:5-12.
97. Manahan-Vaughan D., von Haebler D., Winter C., Juckel G., Heinemann U. A single application of MK-801 causes symptoms of psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus 2008, 18:125-134.
98. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron 1992, 8:653-662.
99. Marcaida G., Felipo V., Hermenegildo C., Minana M.-D., Grisolia S. Acute ammonia toxicity is mediated by the NMDA type of glutamate receptors. FEBS 1992, 296:67-68.
100. Marsden W.N. Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression. Med. Hypotheses 2011, 77:508-528.
101. Martin S.J., Grimwood P.D., Morris R.G.M. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 2000, 23:649-711.
102. Massey P.V., Johnson B.E., Moult P.R., Auberson Y.P., Brown M.W., Molnar E., Collingridge G.L., Bashir Z.I. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J. Neurosci. 2004, 24:7821-7828.
103. Mayer M.L., Armstrong N. Structure and function of glutamate receptor ion channels. Annu. Rev. Physiol. 2004, 66:161-181.
104. McCool B.A. Ethanol modulation of synaptic plasticity. Neuropharmacology 2011, 61:1097-1108.
105. McCormack S.G., Stornetta R.L., Zhu J.J. Synaptic AMPA receptor exchange maintains bidirectional plasticity. Neuron 2006, 50:75-88.
106. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
107. Melendez R.I., Hicks M.P., Cagle S.S., Kalivas P.W. Ethanol exposure decreases glutamate uptake in the nucleus accumbens. Alcohol. Clin. Exp. Res. 2005, 29:326-333.
108. Meredith R.M., Floyer-Lea A., Paulsen O. Maturation of long-term potentiation induction rules in rodent hippocampus: role of GABAergic inhibition. J. Neurosci. 2003, 23:11142-11146.
109. Mennerick S., Zorumski C.F. Postsynaptic modulation of NMDA synaptic currents in rat hippocampal microcultures by paired pulse stimulation. J. Physiol. (London) 1996, 490:405-417.
110. Mennerick S., Zorumski C.F. Survival and neural activity in the developing nervous system. Mol. Neurobiol. 2000, 22:41-54.
111. Milnerwood A.J., Raymond L.A. Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends Neurosci. 2010, 33:513-523.
112. Mitchell N.D., Baker G.B. An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatr. Scand. 2010, 122:192-210.
113. Mockett B., Coussens C., Abraham W.C. NMDA receptor-mediated metaplasticity during the induction of long-term depression by low-frequency stimulation. Eur. J. Neurosci. 2002, 15:1819-1826.
114. Molnar E., Pickard L., Duckworth J.K. Developmental changes in ionotropic glutamate receptors: lessons from hippocampal synapses. Neuroscientist 2002, 8:143-153.
115. Morishita W., Lu W., Smith G.B., Nicoll R.A., Bear M.F., Malenka R.C. Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression. Neuropharmacology 2007, 52:71-76.
116. Nelson E.C., Heath A.C., Bucholz K.K., Madden P.A., Fu Q., Knopik V., Lynskey M.T., Whitfield J.B., Statham D.J., Martin N.G. Genetic epidemiology of alcohol-induced blackouts. Arch. Gen. Psychiatry 2004, 61:257-263.
117. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci. 2001, 69:369-381.
118. Nourry C., Grant S.G., Borg J.P. PDZ domain proteins: plug and play. Sci. STKE 2003, 179:re7.
119. Olney J.W. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 1969, 164:719-721.
120. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 1995, 52:998-1007.
121. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989, 244:1360-1362.
122. Ondrejcak T., Klyubin I., Hu N.W., Barry A.E., Cullen W.K., Rowan M.J. Alzheimer's disease amyloid beta-protein and synaptic function. Neuromol. Med. 2010, 12:13-26.
123. Paoletti P. Molecular basis of NMDA receptor functional diversity. Eur. J. Neurosci. 2011, 33:1351-1365.
124. Peineau S., Taghibiglou C., Bradley C., Wong T.P., Liu L., Lu J., Lo E., Wu D., Saule E., Bouschet T., Matthews P., Isaac J.T.R., Bortolotto Z.A., Wang Y.T., Collingridge G.L. LTP inhibits LTD in the hippocampus via regulation of GSK3β. Neuron 2007, 53:703-717.
125. Pelkey K.A., Askalan R., Paul S., Kalia L.V., Nguyen T.H., Pitcher G.M., Salter M.W., Lombroso P.J. Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron 2002, 34:127-138.
126. Philpot B.D., Espinosa J.S., Bear M.F. Evidence for altered NMDA receptor function as a basis for metaplasticity in visual cortex. J. Neurosci. 2003, 23:5583-5588.
127. Pocklington A.J., Armstrong J.D., Grant S.G. Organization of brain complexity-synapse proteome form and function. Brief Funct. Genomic Proteomic 2006, 5:66-73.
128. Purdy R.H., Morrow A.L., Moore P.H., Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:4553-4557.
129. Raichle M.E., Snyder A.Z. A default mode of brain function: a brief history of an evolving idea. Neuroimage 2007, 37:1083-1090.
130. 2+ release from cyclic ADP-ribose-sensitive stores. J. Neurophysiol. 1999, 82:1569-1576.
131. Ryan B.K., Vollmayr B., Klyubin I., Gass P., Rowan M.J. Persistent Inhibition of hippocampal long-term potentiation in vivo by learned helplessness stress. Hippocampus 2010, 20:758-767.
132. A receptor-modulating 3α-hydrox, 5α-reduced pregnane steroids in the adult rat brain. J. Neuroendocrinol. 2007, 19:272-284.
133. Sacktor T.C. How does PKMζ maintain long-term memory?. Nat. Rev. Neurosci. 2011, 12:9-15.
134. Sacktor T.C., Fenton A.A. Appropriate application of ZIP for PKMζ inhibition, LTP reversal and memory erasure. Hippocampus 2012, Oct 4. doi:10.1002/hipo.20978.
135. 2+ mobilization and ROS generation in rat hippocampal astrocytes. Neurochem. Int. 2008, 52:1061-1067.
136. Sandi C. Glucocorticoids act on glutamatergic pathways to affect memory processes. Trends Neurosci. 2011, 34:165-176.
137. Sanna E., Talani G., Busonero F., Pisu M.G., Purdy R.H., Serra M., Biggio G. Brain steroidogenesis mediates ethanol modulation of GABA-A receptor activity in rat hippocampus. J. Neurosci. 2004, 24:6521-6530.
138. Sawtell N.B., Frenkel M.Y., Philpot B.D., Nakazawa K., Tonegawa S., Bear M.F. NMDA receptor-dependent ocular dominance plasticity in adult visual cortex. Neuron 2003, 38:977-985.
139. A and NMDA receptors in ethanol inhibition of long-term potentiation. Mol. Brain Res. 2001, 94:9-14.
140. Schummers J., Bentz S., Browning M.D. Ethanol's inhibition of LTP may not be mediated solely via direct effects on the NMDA receptor. Alcohol Clin. Exp. Res. 1997, 21:404-408.
141. Selig D.K., Hjelmstad G.O., Herron C., Nicoll R.A., Malenka R.C. Independent mechanisms for long-term depression of AMPA and NMDA responses. Neuron 1995, 15:417-426.
142. Shin L.M., Liberzon I. The neurocircuitry of fear, stress and anxiety disorders. Neuropsychopharmacol. Rev. 2010, 35:169-191.
143. Slutsky I., Abumaria N., Wu L.-J., Huang C., Zhang L., Li B., Zhao X., Govindarajan A., Zhao M.-G., Zhuo M., Tonegawa S., Liu G. Enhancement of learning and memory by elevating brain magnesium. Neuron 2010, 65:165-177.
144. Soriano F.X., Papadia S., Hofmann F., Hardingham N.R., Bading H., Hardingham G.E. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J. Neurosci. 2006, 26:4509-4518.
145. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 2004, 14:311-317.
146. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am. J. Psychiatry 2010, 167:1178-1193.
147. Tokuda K., O'Dell K.A., Izumi Y., Zorumski C.F. Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis. J. Neurosci. 2010, 30:16788-16795.
148. Tokuda K., Izumi Y., Zorumski C.F. Ethanol enhances neurosteroidogenesis in hippocampal pyramidal neurons by paradoxical NMDA receptor activation. J. Neurosci. 2011, 31:9905-9909.
149. Tovar K.R., Westbrook G.L. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 1999, 19:4180-4188.
150. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R. Glutamate receptor ion channels: structure, regulation and function. Pharmacol. Rev. 2010, 62:405-496.
151. Valdez C.M., Smith M.A., Perry G., Phelix C.F., Santamaria F. Cholesterol homeostasis markers are localized to mouse hippocampal pyramidal and granule layers. Hippocampus 2010, 20:902-905.
152. Watkins J.C. l-glutamate as a central transmitter: looking back. Biochem. Soc. Trans. 2000, 28:297-309.
153. Wenthold R.J., Prybylowski K., Standley S., Sans N., Petralia R.S. Trafficking of NMDA receptors. Annu. Rev. Pharmacol. Toxicol. 2003, 43:335-358.
154. White A.M. What happened? Alcohol, memory blackouts and the brain. Alcohol Res. Health 2003, 27:186-196.
155. White A.M., Swartzwelder H.S. Hippocampal function during adolescence: a unique target of ethanol effects. Ann. N. Y. Acad. Sci. 2004, 1021:206-220.
156. Wigstrom H., Gustafsson B. Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition. Nature 1983, 301:603-604.
157. Xu L., Anwyl R., Rowan M.J. Behavioral stress facilitates the induction of long-term depression in the hippocampus. Nature 1997, 387:497-500.
158. Xue J.-G., Masuoka T., Gong X.-D., Chen K.-S., Yanagawa Y., Law S.K.A., Konishi S. NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms. J. Neurophysiol. 2011, 105:2897-2906.
159. Yang C.H., Huang C.C., Hsu K.S. Novelty exploration elicits a reversal of acute stress-induced modulation of hippocampal synaptic plasticity in the rat. J. Physiol. 2006, 577:601-615.
160. Yang P.C., Yang C.H., Huang C.C., Hsu K.S. Phosphatidylinositol 3-kinase activation is required for stress protocol-induced modification of hippocampal synaptic plasticity. J. Biol. Chem. 2008, 283:2631-2643.
161. Youssef F.F., Addae J.I., Stone T.W. NMDA-induced preconditioning attenuates synaptic plasticity in the rat hippocampus. Brain Res. 2006, 1073-1074:183-189.
162. Zajaczkowski W., Frankiewicz T., Parsons C.G., Danysz W. Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP. Neuropharmacology 1997, 36:961-971.
163. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., Manji H.K. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63:856-864.
164. Zeng H., Chattarji S., Barbarosie M., Rondi-Reig L., Philpot B.D., Miyakawa T., Bear M.F., Tonegawa S. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 2001, 107:617-629.
165. Zhu Y., Pak D., Qin Y., McCormack S.G., Kim M.J., Baumgart J.P., Velamoor V., Auberson Y.P., Osten P., van Aelst L., Sheng M., Zhu J.J. Rap-2-JNK removes synaptic AMPA receptors during depotentiation. Neuron 2005, 46:905-916.
166. Zorumski C.F., Olney J.W. Excitotoxic neuronal damage and neuropsychiatric disorders. Pharmacol. Ther. 1993, 59:145-162.
167. Zorumski C.F., Rubin E.H. Psychiatry and Clinical Neuroscience: A Primer 2011, Oxford University Press, New York.
168. Zorumski C.F., Yang J., Fischbach G.D. Calcium dependent, slow desensitization distinguishes different types of glutamate receptors. Cell. Mol. Neurobiol. 1989, 9:95-104.